Molecular Brain (Apr 2022)
Correction to: Oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome
- Tomoya Takemoto,
- Masayuki Baba,
- Kazumasa Yokoyama,
- Kohei Kitagawa,
- Kazuki Nagayasu,
- Yukio Ago,
- Kaoru Seiriki,
- Atsuko Hayata-Takano,
- Atsushi Kasai,
- Daisuke Mori,
- Norio Ozaki,
- Kazuhiro Takuma,
- Ryota Hashimoto,
- Hitoshi Hashimoto,
- Takanobu Nakazawa
Affiliations
- Tomoya Takemoto
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Masayuki Baba
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Kazumasa Yokoyama
- Discovery Accelerator, Astellas Pharma Inc.
- Kohei Kitagawa
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Kazuki Nagayasu
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Yukio Ago
- Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University
- Kaoru Seiriki
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Atsuko Hayata-Takano
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Atsushi Kasai
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Daisuke Mori
- Department of Psychiatry, Nagoya University Graduate School of Medicine
- Norio Ozaki
- Department of Psychiatry, Nagoya University Graduate School of Medicine
- Kazuhiro Takuma
- United Graduate School of Child Development, Molecular Research Center for Children’s Mental Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui
- Ryota Hashimoto
- Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry
- Hitoshi Hashimoto
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- Takanobu Nakazawa
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University
- DOI
- https://doi.org/10.1186/s13041-022-00920-z
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 1
Abstract
No abstracts available.